Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

June 30, 2010

Conditions
Cerebral Stroke
Interventions
DRUG

reboxetine

single dose of 4mg reboxetine 80 minutes before assessment of Jebsen Taylor test

DRUG

Placebo

placebo, 80 min before assessment of Jebsen Taylor test

DEVICE

tDCS verum

20 minutes of 1 mV transcranial direct current stimulation with 5x5 cm electrodes with active electrode over the primary motor representation of the stroke hemisphere and reference electrode over the contralateral supraorbital area Application during assessment of Jebsen Taylor test

DEVICE

tDCS sham

30 seconds of 1 mV transcranial direct current stimulation with 5x5 cm electrodes with active electrode over the primary motor representation of the stroke hemisphere and reference electrode over the contralateral supraorbital area Application during assessment of Jebsen Taylor test

Trial Locations (1)

20246

University Hospital Hamburg-Eppendorf, Department of Neurology, Hamburg

Sponsors
All Listed Sponsors
collaborator

German Research Foundation

OTHER

collaborator

University Hospital Tuebingen

OTHER

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER